Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.10.1 (
ERK
)
95,504
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In
Drosophila
, zygotic genome activation occurs in pre-blastoderm embryos during rapid mitotic divisions. How the transcription machinery is coordinated to achieve this goal in a very brief time span is still poorly understood.
Transcription factor II H
(
TFIIH
) is fundamental for transcription initiation by RNA polymerase II (RNAPII). Herein, we show the
in vivo
dynamics of
TFIIH
at the onset of transcription in
Drosophila
embryos.
TFIIH
shows an oscillatory behaviour between the nucleus and cytoplasm.
TFIIH
foci are observed from interphase to metaphase, and colocalize with those for RNAPII phosphorylated at serine 5 (RNAPIIS5P) at prophase, suggesting that transcription occurs during the first mitotic phases. Furthermore, embryos with defects in subunits of either the
CAK
or the core subcomplexes of
TFIIH
show catastrophic mitosis. Although, transcriptome analyses show altered expression of several maternal genes that participate in mitosis, the global level of RNAPIIS5P in
TFIIH
mutant embryos is similar to that in the wild type, therefore, a direct role for
TFIIH
in mitosis cannot be ruled out. These results provide important insights regarding the role of a basal transcription machinery component when the zygotic genome is activated.
...
PMID:TFIIH localization is highly dynamic during zygotic genome activation in
Drosophila
, and its depletion causes catastrophic mitosis. 2964 18